Mablink Bioscience
- Website
- mablink.com
- Total Funding
- $40.5M
- Last Round
- $35.6M Series AOct 2022
- Rounds
- 2
About
PSARlink drug-linker technology for antibody-drug conjugates
Summary
It has raised $40.5M in total across 2 rounds, most recently a $35.6M Series A round in Oct 2022. Investors include Sofinnova Partners, Mérieux Equity Partners and Elaia.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.